Report Detail

Pharma & Healthcare Global Contraceptive Drugs and Devices Market Insights, Forecast to 2025

  • RnM2365711
  • |
  • 16 May, 2019
  • |
  • Global
  • |
  • 117 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Contraceptive Drugs and Devices Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Contraceptive Drugs and Devices Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Contraceptive Drugs and Devices Market Size Growth Rate by Product
      • 1.4.2 Oral
      • 1.4.3 Vaginal
      • 1.4.4 Injectable Contraceptive Drugs
      • 1.4.5 Male/Female Contraceptive Devices
    • 1.5 Market by End User
      • 1.5.1 Global Contraceptive Drugs and Devices Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Pharmacies
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Contraceptive Drugs and Devices Market Size
      • 2.1.1 Global Contraceptive Drugs and Devices Revenue 2014-2025
      • 2.1.2 Global Contraceptive Drugs and Devices Sales 2014-2025
    • 2.2 Contraceptive Drugs and Devices Growth Rate by Regions
      • 2.2.1 Global Contraceptive Drugs and Devices Sales by Regions
      • 2.2.2 Global Contraceptive Drugs and Devices Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Contraceptive Drugs and Devices Sales by Manufacturers
      • 3.1.1 Contraceptive Drugs and Devices Sales by Manufacturers
      • 3.1.2 Contraceptive Drugs and Devices Sales Market Share by Manufacturers
      • 3.1.3 Global Contraceptive Drugs and Devices Market Concentration Ratio (CR5 and HHI)
    • 3.2 Contraceptive Drugs and Devices Revenue by Manufacturers
      • 3.2.1 Contraceptive Drugs and Devices Revenue by Manufacturers (2014-2019)
      • 3.2.2 Contraceptive Drugs and Devices Revenue Share by Manufacturers (2014-2019)
    • 3.3 Contraceptive Drugs and Devices Price by Manufacturers
    • 3.4 Contraceptive Drugs and Devices Manufacturing Base Distribution, Product Types
      • 3.4.1 Contraceptive Drugs and Devices Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Contraceptive Drugs and Devices Product Type
      • 3.4.3 Date of International Manufacturers Enter into Contraceptive Drugs and Devices Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Contraceptive Drugs and Devices Sales by Product
    • 4.2 Global Contraceptive Drugs and Devices Revenue by Product
    • 4.3 Contraceptive Drugs and Devices Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Contraceptive Drugs and Devices Breakdown Data by End User

    6 North America

    • 6.1 North America Contraceptive Drugs and Devices by Countries
      • 6.1.1 North America Contraceptive Drugs and Devices Sales by Countries
      • 6.1.2 North America Contraceptive Drugs and Devices Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Contraceptive Drugs and Devices by Product
    • 6.3 North America Contraceptive Drugs and Devices by End User

    7 Europe

    • 7.1 Europe Contraceptive Drugs and Devices by Countries
      • 7.1.1 Europe Contraceptive Drugs and Devices Sales by Countries
      • 7.1.2 Europe Contraceptive Drugs and Devices Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Contraceptive Drugs and Devices by Product
    • 7.3 Europe Contraceptive Drugs and Devices by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Contraceptive Drugs and Devices by Countries
      • 8.1.1 Asia Pacific Contraceptive Drugs and Devices Sales by Countries
      • 8.1.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Contraceptive Drugs and Devices by Product
    • 8.3 Asia Pacific Contraceptive Drugs and Devices by End User

    9 Central & South America

    • 9.1 Central & South America Contraceptive Drugs and Devices by Countries
      • 9.1.1 Central & South America Contraceptive Drugs and Devices Sales by Countries
      • 9.1.2 Central & South America Contraceptive Drugs and Devices Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Contraceptive Drugs and Devices by Product
    • 9.3 Central & South America Contraceptive Drugs and Devices by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Contraceptive Drugs and Devices by Countries
      • 10.1.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Countries
      • 10.1.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Contraceptive Drugs and Devices by Product
    • 10.3 Middle East and Africa Contraceptive Drugs and Devices by End User

    11 Company Profiles

    • 11.1 Bayer Healthcare
      • 11.1.1 Bayer Healthcare Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Bayer Healthcare Contraceptive Drugs and Devices Products Offered
      • 11.1.5 Bayer Healthcare Recent Development
    • 11.2 Merck
      • 11.2.1 Merck Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Merck Contraceptive Drugs and Devices Products Offered
      • 11.2.5 Merck Recent Development
    • 11.3 Church & Dwight
      • 11.3.1 Church & Dwight Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Church & Dwight Contraceptive Drugs and Devices Products Offered
      • 11.3.5 Church & Dwight Recent Development
    • 11.4 Warmer Chilcott
      • 11.4.1 Warmer Chilcott Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Warmer Chilcott Contraceptive Drugs and Devices Products Offered
      • 11.4.5 Warmer Chilcott Recent Development
    • 11.5 Agile Therapeutics
      • 11.5.1 Agile Therapeutics Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Agile Therapeutics Contraceptive Drugs and Devices Products Offered
      • 11.5.5 Agile Therapeutics Recent Development
    • 11.6 Pfizer
      • 11.6.1 Pfizer Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Pfizer Contraceptive Drugs and Devices Products Offered
      • 11.6.5 Pfizer Recent Development
    • 11.7 BioSante Pharmaceuticals
      • 11.7.1 BioSante Pharmaceuticals Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Products Offered
      • 11.7.5 BioSante Pharmaceuticals Recent Development
    • 11.8 Mayer Laboratories
      • 11.8.1 Mayer Laboratories Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Mayer Laboratories Contraceptive Drugs and Devices Products Offered
      • 11.8.5 Mayer Laboratories Recent Development
    • 11.9 Pantarhei Bioscience
      • 11.9.1 Pantarhei Bioscience Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Pantarhei Bioscience Contraceptive Drugs and Devices Products Offered
      • 11.9.5 Pantarhei Bioscience Recent Development
    • 11.10 Teva Pharmaceutical Industries
      • 11.10.1 Teva Pharmaceutical Industries Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Products Offered
      • 11.10.5 Teva Pharmaceutical Industries Recent Development

    12 Future Forecast

    • 12.1 Contraceptive Drugs and Devices Market Forecast by Regions
      • 12.1.1 Global Contraceptive Drugs and Devices Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Contraceptive Drugs and Devices Revenue Forecast by Regions 2019-2025
    • 12.2 Contraceptive Drugs and Devices Market Forecast by Product
      • 12.2.1 Global Contraceptive Drugs and Devices Sales Forecast by Product 2019-2025
      • 12.2.2 Global Contraceptive Drugs and Devices Revenue Forecast by Product 2019-2025
    • 12.3 Contraceptive Drugs and Devices Market Forecast by End User
    • 12.4 North America Contraceptive Drugs and Devices Forecast
    • 12.5 Europe Contraceptive Drugs and Devices Forecast
    • 12.6 Asia Pacific Contraceptive Drugs and Devices Forecast
    • 12.7 Central & South America Contraceptive Drugs and Devices Forecast
    • 12.8 Middle East and Africa Contraceptive Drugs and Devices Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Contraceptive Drugs and Devices Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      A contraceptive is a device or drug that prevents a woman from becoming pregnant.
      The key factors contributing to the contraceptive drugs and devices market are growing prevalence of sexually transmitted diseases and the growing need to control the rising population.
      The global Contraceptive Drugs and Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Contraceptive Drugs and Devices market based on company, product type, end user and key regions.

      This report studies the global market size of Contraceptive Drugs and Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Contraceptive Drugs and Devices in these regions.
      This research report categorizes the global Contraceptive Drugs and Devices market by top players/brands, region, type and end user. This report also studies the global Contraceptive Drugs and Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Bayer Healthcare
      Merck
      Church & Dwight
      Warmer Chilcott
      Agile Therapeutics
      Pfizer
      BioSante Pharmaceuticals
      Mayer Laboratories
      Pantarhei Bioscience
      Teva Pharmaceutical Industries

      Market size by Product
      Oral
      Vaginal
      Injectable Contraceptive Drugs
      Male/Female Contraceptive Devices
      Market size by End User
      Hospitals
      Pharmacies
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Contraceptive Drugs and Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Contraceptive Drugs and Devices market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Contraceptive Drugs and Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Contraceptive Drugs and Devices submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Contraceptive Drugs and Devices are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Contraceptive Drugs and Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Contraceptive Drugs and Devices . Industry analysis & Market Report on Contraceptive Drugs and Devices is a syndicated market report, published as Global Contraceptive Drugs and Devices Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Contraceptive Drugs and Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,117.38
      4,676.07
      6,234.76
      3,473.32
      5,209.99
      6,946.65
      420,162.60
      630,243.90
      840,325.20
      268,524.36
      402,786.54
      537,048.72
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report